Contralateral Recurrence Of Inflammatory Myofibroblastic Tumour Of The Lung Ten Years After Pneumonectomy
THORAX(2017)
Abstract
Inflammatory myofibroblastic tumour (IMT) is a rare form of inflammatory pseudotumour of the lung. Complete surgical resection is the treatment of choice, with corticosteroid-based medical therapy reserved for cases where complete resection is not possible.1 To date, the majority of recurrent cases have occurred subsequent to incomplete resection or after discontinuation of steroids when used as primary therapy.1 2 There is a paucity of data guiding the follow-up of patients who undergo complete resection. In addition, the efficacy of oral steroids in the treatment of IMT remains poorly characterised and the optimal duration of therapy is unknown.A 46-year-old lifetime non-smoker presented in December 2015 with dyspnoea, fatigue, night sweats and weight loss. A chest X-ray demonstrated a new left lower lobe mass. His history was significant only for a right pneumonectomy in June 2005 for a large inflammatory pseudotumour. This pneumonectomy was performed for definitive surgical management, as the mass was adjacent to …
MoreTranslated text
Key words
rare lung diseases,thoracic surgery,imaging,CT,MRI,etc,histology,cytology
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined